ASBMT Clinical Research Training Course 2018
The ASBMT Board of Directors created the course in 2006 because of concerns that clinical fellowship programs don’t adequately cover the principles of research and how to take findings from the laboratory to the clinic. The course helps close the gap by addressing those deficiencies. The course includes formal presentations and extensive follow-up dialogue and small-group discussion, covering topics such as:
- Research subject eligibility and recruitment
- Clinical trial design
- Data management and quality control
- Study endpoints
- Late effects and quality of life
- Clinical pharmacology, including polypharmacy and drug interactions
- Regulatory compliance
- Relationships with pharmaceutical companies and third-party payers
- Opportunities for grants and clinical research training
- Grant writing
- Working with a mentor
- Translational trials
- Working with laboratory investigators
- Research ethics
- Subject safety
Each participant will be expected to have a research project that can be developed in discussions with faculty and with peers.
The 2018 course directors are Christopher N. Bredeson, MD, MSc, The Ottawa Hospital/University of Ottawa and Margaret MacMillan, MD, MSc, University of Minnesota.
Faculty members will share their career stories and anecdotes. They will tell how they got where they are and the lessons learned along with way. Free time for rest, recreation and creative thinking will be built into the schedule.
Eligibility and Application
An applicant must be an ASBMT member or sponsored by an ASBMT member. For purposes of this program, "junior faculty” is defined as two years or less teaching in the BMT field.
The applicant must identify a local mentor with whom to work in implementation of the research project after the course.
This educational activity is being supported by: Jazz Pharmaceuticals, Incyte, and Merck & Co. Inc.
Physicians and allied health professionals
At the conclusion of this activity, scholars should be able to:
- Provide Scholars with an opportunity to present their research to their peers and BMT Faculty
- Provide Scholars with critical input regarding clinical trial design and implementation.
- Prepare Scholars for presenting their research at national meetings
- Foster mentoring and networking between faculty and scholars in an intimate environment
- Reinforce participants’ commitment to the stem cell transplantation community
Christopher N. Bredeson, MD, MSc - University of Ottawa
Margaret MacMillan, MD - University of Minnesota
Margaret MacMillian, MD
Brenda Sandmaier, MD
Pfizer, Kiadis, AnaptysBio
Carlos A. Ramos, MD
Tessa Therapeutics, Novartis, Celgene
PI, Advisory Board
Joycelynne Palmer, PhD
Gilead Sciences Inc.
Nohla Therapeutics, Pharmacyclics, Kiadis
Consultant, DMC Member
Marcos de Lima
Celgene, Pfizer, Kiadis
Bristol-Myers Squibb, Pfizer, Astellas, Incyte, Jazz, ElsaLys
Merck, Incyte, Seattle Genetics, Inc.
Advisory Board, Speaker
Otsuka, Celegene, Jazz, Kite Pharma
Novartis, Celgene, Nkarta
- 35.25 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 35.25 Hours of ParticipationHours of Participation credit.